StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Nitrazepam

HCID 4506
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
146-22-5
Standard-SMILES
O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1
InChIKey
KJONHKAYOJNZEC-UHFFFAOYSA-N
Summenformel
C15H11N3O3
Durchschnittliche Molmasse
281,27 g/mol
Monoisotopische Masse
281,08004122

Überblick

Nitrazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). It has a role as an anticonvulsant, a sedative, a drug metabolite, a GABA modulator and an antispasmodic drug. It is a 1,4-benzodiazepinone and a C-nitro compound.

Namen und Bezeichner

Bevorzugter Name
Nitrazepam
IUPAC
7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
Lokaler Name
Nitrazepam
Englischer Name
Nitrazepam
Summenformel
C15H11N3O3
Molmasse
281.27

Namen und Synonyme

nitrazepamBenzalin146-22-5MogadonRadedormApodormCalsminEunoctinNeozepamNeuchlonicNitradosSonebon
Weitere Namen anzeigen
Ntz1,3-dihydro-7-nitro-5-phenyl-2h-4-benzodiazepin-2-onela1Nitrazepam (CRM)1,3-dihydro-7-nitro-5-phenyl-1,4-benzodiazepin-2-one7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-oneLA 1Eatan
HipsalImesonRemnosSuremSomitranSonnolinTrazeninUnisomnia

Datenbank-Bezeichner

CAS
146-22-5
PubChem CID
4506
DTXSID
DTXSID5023372
ChEMBL
CHEMBL13209
ChEBI
CHEBI:7581

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,2
Polarare Oberfläche (TPSA)
87,3 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
1
Schwere Atome
21
Formalladung
0
Komplexität
452

Experimentelle und physikochemische Eigenschaften

Drugs · 6 Einträge

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Benzodiazepines

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP · 2 Einträge

2.25

2.06

Solubility · 2 Einträge

2.99e-02 g/L

>42.2 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 2 Einträge

Breast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Anti-Anxiety Agents; Benzodiazepines

Pharmaceuticals

Melting Point225 °C
Physical DescriptionSolid
Collision Cross Section · 2 Einträge

166.3 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated]

163.6 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 49 reports by companies from 3 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory Information · 2 Einträge

DEA schedule IV controlled substance

Nitrazepam: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

Treatment · 1 Eintrag

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

N05CD02

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1 Eintrag

Nitrazepam is a type of benzodiazepine drug. It is a powerful hypnotic drug which possesses strong sedative, anxiolytic, amnestic, anticonvulsant, and skeletal muscle relaxant properties. Nitrazepam shortens the time required to fall asleep and lengthens the duration of sleep. It is also useful for the management of myoclonic seizures.

Mechanism of Action · 1 Eintrag

Nitrazepam belongs to a group of medicines called benzodiazepines. This drug affects central benzodiazepine receptors, which are associated with inhibitory GABA (gamma amino butyric acid)receptors, leading to enhanced GABA binding activity. GABA is a major neurotransmitter in the brain, which causes somnolence, relaxation of muscles, a decrease in anxiety and general central nervous system depression. Nitrazepam has anticonvulsant properties that may be attributed to its ability to bind to voltage-dependent sodium channels. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.

Biological Half-Life15-38 hours (mean elimination half life 26 hours).
Metabolism/MetabolitesIt is long acting, is lipophilic and is metabolised hepatically via oxidative pathways. [Wikipedia] Half Life: 15-38 hours (mean elimination half life 26 hours).
MeSH Pharmacological Classification · 4 Einträge

Drugs used to prevent SEIZURES or reduce their severity.

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.

Zugehörige Reaktionen

7
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 135958
HRID 135958als Edukt
Reaktionsgleichung von HRID 214363
HRID 214363als Edukt
Reaktionsgleichung von HRID 697239
HRID 697239als Edukt
Reaktionsgleichung von HRID 865711
HRID 865711als Edukt
Reaktionsgleichung von HRID 1729599
HRID 1729599als Edukt
Reaktionsgleichung von HRID 1973059
HRID 1973059als Produkt
Reaktionsgleichung von HRID 2418314
HRID 2418314als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
UNII
9CLV70W7HS
EC Number
205-665-2
Nikkaji
J2.956D

Physikochemische Eigenschaften

Schmelzpunkt
223 · 223-227C
Siedepunkt
423.94 °C · 423.94°C (rough estimate)
Dichte
1.2309 · 1.2309 (rough estimate)
Brechungsindex
1.57 · 1.5700 (estimate)
Flammpunkt
2 ℃ · 2℃
storage temp.
-20 °C · Controlled Substance, -20°C Freezer
Löslichkeit
Practically insoluble in water, slightly soluble in ethanol (96 per cent).
pka
2.9 · pKa 2.90 ± 0.05;10.39±0.04(H2O,t =25,I=0.015(KCl))(Approximate)
Wasserlöslichkeit
3.93 mg/L · 3.93mg/L(25 ºC)
Major Application
pharmaceutical (small molecule)
InChI
1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)
InChIKey
KJONHKAYOJNZEC-UHFFFAOYSA-N
SMILES
[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3)c2c1
CAS Datenbank
146 · 146-22-5(CAS DataBase Reference)
NIST chemische Informationen
Nitrazepam(146-22-5)
EPA chemische Informationen
2 H-1,4-Benzodiazepin-2-one, · 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl- (146-22-5)
Health Effects · 1 Eintrag

They cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive. May cause a potentially dangerous rash that may develop into Stevens Johnson syndrome, an extremely rare but potentially fatal skin disease.

Exposure RoutesBioavailability is 53-94% following oral administration.
Toxicity Summary · 1 Eintrag

Nitrazepam belongs to a group of medicines called benzodiazepines. It acts on benzodiazepine receptors in the brain which are associated with the GABA receptors causing an enhanced binding of GABA (gamma amino butyric acid) to GABAA receptors. GABA is a major inhibitory neurotransmitter in the brain, involved in inducing sleepiness, muscular relaxation and control of anxiety and fits, and slows down the central nervous system. The anticonvulsant properties of nitrazepam and other benzodiazepines may be in part or entirely due to binding to voltage-dependent sodium channels rather than benzodiazepine receptors. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.

Signs and Symptoms · 1 Eintrag

Nitrazepam is a drug which is very frequently involved in drug intoxication, including overdose. Nitrazepam overdose may result in stereotypical symptoms of benzodiazepine overdose including intoxication, impaired balance, slurred speech. In cases of severe overdose this may progress to a comatose state with the possibility of death.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 4 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Nitrazepam

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

wgk
3
ridadr
3249
RTECS-Nr.
DF2450000
risk_code
22-36-20/21/22-11
Toxizität
LD50 orally in rats: 825 ±80 mg/kg (Randall)
hazard_code
Xn,F
safety_code
36/37/39-36/37-16
hazard_class
6.1(b)
packing_group
III
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 Oral
Absorption, Distribution and ExcretionBioavailability is 53-94% following oral administration.
Cellular LocationsMembrane

Verwendung und Herstellung

Uses · 2 Einträge

Use (kg; approx.) in Germany (2009): ?100

Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.

Use ClassificationPharmaceuticals

Anwendungen

VerwendenAnticonvulsant; hypnotic. Controlled substance (depressant)

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

2-ChloracetamidChloracetylchlorid2-Amino-5-nitrobenzophenon4-ChloranilinMethenaminBenzoylchloridSalpetersureEthylglycinathydrochlorid2-AminobenzophenonAcetamide, 2-amino-N-(2-benzoyl-4-nitrophenyl)-1,3-Dihydro-5-phenyl-2H-1,4-benzodiazepin-2-onN-(2-Benzoyl-4-nitrophenyl)-2-chloracetamidToluol-4-sulfonsure
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the trea ment of epileptic spasms in infants (West's syndrome).